PT  - JOURNAL ARTICLE
AU  - Jo Thompson
TI  - Deprescribing in palliative care
AID  - 10.7861/clinmedicine.19-4-311
DP  - 2019 Jul 01
TA  - Clinical Medicine
PG  - 311--314
VI  - 19
IP  - 4
4099  - http://www.rcpjournals.org/content/19/4/311.short
4100  - http://www.rcpjournals.org/content/19/4/311.full
SO  - Clin Med2019 Jul 01; 19
AB  - The use of multiple medications is common in palliative care, putting patients at risk of adverse events and a high tablet burden. Deprescribing is the process of reviewing and stopping potentially inappropriate medications in order to improve quality of life. Barriers to deprescribing exist meaning many patients will take multiple medications despite being in the final months of life. The OncPal deprescribing guideline is a useful tool to support the process for patients with a limited life expectancy. There is evidence for the safety of stopping certain medications, particularly those aimed at primary prevention. A systematic process of reviewing individual medications and their appropriateness is recommended.